Protein nanovaccine confers robust immunity against Toxoplasma.

about

Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus

P2860

Q56567289-20A6B610-47BA-45F4-A0AB-63C7A4FEBF0F Q57131555-AEF5974B-16D5-47FF-ADB8-7F3FAA59572A

P2860

Protein nanovaccine confers robust immunity against Toxoplasma.

Item

http://www.wikidata.org/entity/Q47102683

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Protein nanovaccine confers robust immunity against Toxoplasma.

@en

Protein nanovaccine confers robust immunity against Toxoplasma.

@nl

type

Item

label

Protein nanovaccine confers robust immunity against Toxoplasma.

@en

Protein nanovaccine confers robust immunity against Toxoplasma.

@nl

prefLabel

Protein nanovaccine confers robust immunity against Toxoplasma.

@en

Protein nanovaccine confers robust immunity against Toxoplasma.

@nl

P1476

Protein nanovaccine confers robust immunity against Toxoplasma.

@en

P2093

Chris Fox

http://www.w3.org/2001/XMLSchema#string

Christopher P Karch

http://www.w3.org/2001/XMLSchema#string

David E Lanar

http://www.w3.org/2001/XMLSchema#string

Ian J Begeman

http://www.w3.org/2001/XMLSchema#string

Jeff Alexander

http://www.w3.org/2001/XMLSchema#string

John Sidney

http://www.w3.org/2001/XMLSchema#string

Kamal El Bissati

http://www.w3.org/2001/XMLSchema#string

Peter Burkhard

http://www.w3.org/2001/XMLSchema#string

Rima McLeod

http://www.w3.org/2001/XMLSchema#string

Sara Maria Paulillo

http://www.w3.org/2001/XMLSchema#string

P2860

Why prevent, diagnose and treat congenital toxoplasmosis?

Malaria vaccine based on self-assembling protein nanoparticles

Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice

Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.

Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restri

Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201

Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice

Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice

P2888

s41541-017-0024-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41541-017-0024-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29263879

http://www.w3.org/2001/XMLSchema#string

P932

5627305

http://www.w3.org/2001/XMLSchema#string

Protein nanovaccine confers robust immunity against Toxoplasma.

about

P2860

P2860

Protein nanovaccine confers robust immunity against Toxoplasma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P698

P932